Showing 81 - 100 results of 2,092 for search '"chemotherapy"', query time: 0.06s Refine Results
  1. 81

    G-CSF-Associated Bone Marrow Necrosis in AML after Induction Chemotherapy by Ikenna Osuorji, Lyle Goldman

    Published 2012-01-01
    “…We report a case of 66-year-old male with AML-M4 (FAB classification) who was given induction chemotherapy with cytarabine and daunorubicin. Filgrastim at 480 micrograms was administered on days 15–19 to shorten the duration of neutropenia. …”
    Get full text
    Article
  2. 82

    Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy by Hampig Raphael Kourie, Joelle Antoun, Alexandre Schakal, Elie Nasr, Marwan Sahyoun, Joseph Kattan

    Published 2015-01-01
    “…This case report demonstrates the importance of the systemic bevacizumab and chemotherapy in the treatment of choroidal metastasis from adenocarcinoma of the lung.…”
    Get full text
    Article
  3. 83

    Dynamics of a Breast Cancer Model for Neutropenia Case due to Chemotherapy Effects by M. Ivan Ariful Fathoni, Fajar Adi-Kusumo, Gunardi Gunardi, Susanna Hilda Hutajulu

    Published 2021-01-01
    “…The neutrophil is one of the cells that is influenced by chemotherapy drugs. Chemotherapy-induced neutropenia is one of the most common toxic effects experienced by patients and often threatens chemotherapy to use efficiency. …”
    Get full text
    Article
  4. 84

    Application and Effect of the Gymnastic Exercise Mode during Chemotherapy for Breast Cancer Patients by Feifei Xie

    Published 2020-01-01
    “…In the past ten years, the incidence rate of breast cancer in China’s major cities has increased by 37%, far higher than that in Europe and America. At present, chemotherapy and radiotherapy are the main treatment methods for breast cancer, but many patients will have cancer-related fatigue after surgery. …”
    Get full text
    Article
  5. 85

    Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy by İlker Selçuk, İpek Düzgüner, Sevda Baş, Taner Turan, Afra Alkan, Nurettin Boran, Mehmet Mutlu Meydanlı, Gökhan Tulunay

    Published 2015-04-01
    “…Additionally, three and five years overall survival was not significantly different (p=0.891) between the platinum and doxorubicin based chemotherapy protocols. DISCUSSION: We did not find a significant difference in terms of disease free survival and overall survival between platinum and doxorubicin based adjuvant chemotherapy protocols in women with ovarian carcinosarcoma. …”
    Get full text
    Article
  6. 86

    Small Cell Neuroendocrine Carcinoma of the Urinary Tract Successfully Managed with Neoadjuvant Chemotherapy by Mustapha Ahsaini, Omar Riyach, Mohammed Fadl Tazi, Mohammed Jamal El Fassi, My Hassan Farih, Hind Elfatmi, Afaf Amarti

    Published 2013-01-01
    “…Neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin was realized, and nephroureterectomy associated to a cystoprostatectomy was carried out. …”
    Get full text
    Article
  7. 87
  8. 88
  9. 89
  10. 90

    Sarcopenia as a Prognostic Factor of Hepatotoxicity and Lower Survival Rate in Chemotherapy of Pancreatic Cancer by A. A. Klunichenko, A. P. Seryakov, A. A. Seryakova, S. M. Demidov

    Published 2020-07-01
    “…A retro-prospective study included 66 patients (30 men and 36 women) with locally advanced and metastatic PC receiving chemotherapy treatment in the form of gemcitabine monotherapy and in combination with platinum, taxanes, fluoropyrimidines in standard chemotherapy protocols. …”
    Get full text
    Article
  11. 91

    Chemotherapy as a Remedy to Gynaecological Cancers: Challenges and Coping Patterns Among Young Women by Titilayo Omolekan, Gbemisola Bolanle Ogbeye, Risikat Idowu Fadare

    Published 2025-01-01
    “…Efforts must be increased to conduct research on the preservation of fertility and sexuality in young women living with gynaecological cancers while receiving chemotherapy.…”
    Get full text
    Article
  12. 92

    Can Gastric Cancer Patients with High Mandard Score Benefit from Neoadjuvant Chemotherapy? by Wen-Zhe Kang, Bing-Zhi Wang, Deng-Feng Li, Zhi-Chao Jiang, Jian-Ping Xiong, Yang Li, Peng Jin, Xin-Xin Shao, Hai-Tao Hu, Yan-Tao Tian

    Published 2022-01-01
    “…A high Mandard score does not mean neoadjuvant chemotherapy is ineffective in gastric cancer. Patients with imaging evaluation of tumor regression and ypN stage reduction may benefit from neoadjuvant chemotherapy.…”
    Get full text
    Article
  13. 93
  14. 94

    Clinical Effectiveness of Neoadjuvant Chemotherapy in Gastric Carcinoma and Exploration of Perioperative Imaging Assessment Parameters by Jiajun Lai, Junsheng Li, Xianwei Mo

    Published 2021-01-01
    “…Due to the difficulty in clinical staging, a simple and feasible perioperative assessment approach for guiding personalized neoadjuvant chemotherapy (NAC) is lacking. We investigated the clinical value of NAC in advanced gastric carcinoma (GC) and the concordance between perioperative imaging and postoperative pathological assessments. …”
    Get full text
    Article
  15. 95
  16. 96

    Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery by Yonghe Chen, Dan Liu, Jian Xiao, Jun Xiang, Aihong Liu, Shi Chen, Junjie Liu, Xiansheng Hu, Junsheng Peng

    Published 2021-01-01
    “…Background. Neoadjuvant chemotherapy (NAC) with subsequent radical surgery has become a popular treatment modality for advanced gastric cancer (AGC) worldwide. …”
    Get full text
    Article
  17. 97

    A Mathematical Model of Tumor-Immune and Host Cells Interactions with Chemotherapy and Optimal Control by Tarekegn Dinku, Boka Kumsa, Jyotirmoy Rana, Aiyappan Srinivasan

    Published 2024-01-01
    “…In this article, we propose the interaction of tumor cells with the immune system in the presence of chemotherapy. The existence, uniqueness, non-negativity, and boundedness of the solutions have been established. …”
    Get full text
    Article
  18. 98
  19. 99
  20. 100